₹94.66
−5.00%NSE close, 16 Nov 2026
+101.53%
Morepen Laboratories is a small cap company, listed on NSE under the symbol MOREPENLAB. At ₹94.66 a share, the market values the whole company at ₹5,187 crore.
In FY26, it reported sales of ₹1,806 crore and a net profit of ₹95 crore, an operating margin of 7.0%. Over the last three years, sales grew 5.3% a year and net profit fell 2.3% a year.
The market values the company at 27.5 times its profit over the last twelve months and 3.76 times its book value; its return on equity is 13.7% and its borrowings are 0.22 times its equity.
Promoters hold 35.65% of the shares. Foreign institutions hold 3.43%, and domestic institutions, mutual funds among them, 1.71%.
Over the past year the share price has risen 99.4%, and it is 37.2% below its 52-week high.
₹ crore. Consolidated figures.
Morepen enters U.S. prescription generics market, building on its established API strengths
Resignation of Mr. Nishant Jayesh Doshi as Vice President - Corporate Finance & Investor Relations, a Senior Management Personnel of the company w.e.f. October 31, 2026.
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 445 | 423 | 455 | 438 | 453 | 466 | 425 | 412 | 484 | 485 | 570 | 747 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 394 | 375 | 404 | 394 | 417 | 424 | 401 | 381 | 438 | 460 | 488 | 623 |
| Operating profit | 50.6 | 48.4 | 51.6 | 44.1 | 36.1 | 42.2 | 24.2 | 30.7 | 46.3 | 24.5 | 82.5 | 123 |
| Operating margin | 11.4% | 11.4% | 11.3% | 10.1% | 8.0% | 9.1% | 5.7% | 7.5% | 9.6% | 5.0% | 14.5% | 16.5% |
| Other income | 4.1 | 4.2 | 3.4 | 5.0 | 5.3 | 4.6 | 4.4 | 4.6 | 3.8 | 8.5 | 5.2 | 8.7 |
| Interest | 2.2 | 0.8 | 1.2 | 1.2 | 1.3 | 4.7 | 4.0 | 4.2 | 4.3 | 3.9 | 4.8 | 5.2 |
| Depreciation | 8.5 | 9.6 | 5.7 | 1.9 | 4.9 | 16.5 | 9.0 | 11.3 | 10.4 | 5.8 | 8.4 | 10.1 |
| Profit before tax | 44.0 | 42.2 | 48.2 | 46.0 | 35.2 | 25.7 | 15.5 | 45.7 | 35.4 | 23.3 | 74.5 | 117 |
| Tax | 12.0 | 13.5 | 12.0 | 11.2 | 8.5 | 5.4 | 4.1 | 4.7 | 7.9 | 7.6 | 18.2 | 27.7 |
| Net profit | 32.0 | 28.3 | 36.2 | 34.9 | 26.7 | 20.3 | 10.8 | 40.9 | 27.5 | 15.7 | 56.4 | 88.9 |
| EPS (₹) | 0.63 | 0.54 | 0.71 | 0.65 | 0.49 | 0.35 | 0.20 | 0.75 | 0.50 | 0.28 | 1.03 | 1.62 |
₹ crore, financial years to March.
| Line | FY19 | FY20 | FY21 | FY22 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Sales | 769 | 853 | 1,188 | 1,547 | 1,690 | 1,812 | 1,806 |
| Expenses | 701 | 785 | 1,070 | 1,410 | 1,532 | 1,638 | 1,680 |
| Operating profit | 67.5 | 68.5 | 119 | 137 | 159 | 174 | 126 |
| Operating margin | 8.8% | 8.0% | 10.0% | 8.8% | 9.4% | 9.6% | 7.0% |
| Other income | 3.7 | 9.5 | 12.1 | 10.3 | 14.0 | 18.4 | 21.3 |
| Interest | 2.1 | 2.0 | 1.8 | −7.4 | 3.7 | 8.3 | 16.4 |
| Depreciation | 39.9 | 36.9 | 30.3 | 27.6 | 33.5 | 29.0 | 36.4 |
| Profit before tax | 29.2 | 39.1 | 98.5 | 127 | 135 | 155 | 120 |
| Tax | 0.3 | 5.5 | 1.4 | 25.0 | 38.8 | 37.1 | 24.3 |
| Net profit | 28.9 | 33.6 | 97.1 | 102 | 96.2 | 118 | 94.9 |
| EPS (₹) | 0.64 | 0.75 | 2.16 | 2.26 | 1.88 | 2.20 | 1.73 |
₹ crore, at each year's end and the latest half year.
| Line | FY23 | FY24 | FY25 | FY26 | Sep 2026 |
|---|---|---|---|---|---|
| Shareholders’ equity | 753 | 847 | 1,156 | 1,246 | 1,381 |
| Borrowings | 25.2 | 29.0 | 79.4 | 195 | 305 |
| Total liabilities | 358 | 446 | 591 | 689 | 924 |
| Fixed assets | 167 | 213 | 317 | 381 | 421 |
| Investments | 0 | 1.3 | 7.2 | 101 | 102 |
| Cash and equivalents | 21.7 | 17.0 | 27.4 | 31.2 | 155 |
| Total assets | 1,111 | 1,293 | 1,778 | 1,936 | 2,306 |
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | −57.8 | 32.1 | 32.6 | 127 |
| From investing | −31.7 | −322 | −123 | −105 |
| From financing | 63.9 | 300 | 97.4 | 102 |
| Spent on fixed assets | −45.5 | −124 | −85.5 | −64.8 |
| Free cash flow | −103 | −92.0 | −52.9 | 62.7 |
Margins, returns, debt, tax and cash.
| Line | FY19 | FY20 | FY21 | FY22 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Net margin | 3.8% | 3.9% | 8.2% | 6.6% | 5.7% | 6.5% | 5.3% |
| Operating margin | 8.8% | 8.0% | 10.0% | 8.8% | 9.4% | 9.6% | 7.0% |
| Return on equity | – | – | – | – | 11.3% | 10.2% | 7.6% |
| Return on capital employed | – | – | – | – | 15.9% | 13.2% | 9.5% |
| Return on assets | – | – | – | – | 7.4% | 6.6% | 4.9% |
| Debt to equity | – | – | – | – | 0.03 | 0.07 | 0.16 |
| Interest coverage | 14.80 | 20.80 | 56.00 | – | 37.50 | 19.60 | 8.30 |
| Debt to assets | – | – | – | – | 0.02 | 0.04 | 0.10 |
| Current ratio | – | – | – | – | 2.21 | 2.32 | 2.37 |
| Quick ratio | – | – | – | – | 1.59 | 1.72 | 1.82 |
| Cash ratio | – | – | – | – | 0.04 | 0.05 | 0.06 |
| Asset turnover | – | – | – | – | 1.31 | 1.02 | 0.93 |
| Fixed asset turnover | – | – | – | – | 7.93 | 5.72 | 4.74 |
| Inventory turnover | – | – | – | – | 4.30 | 3.90 | 4.10 |
| Receivables turnover | – | – | – | – | 5.20 | 5.60 | 5.40 |
| Gross margin | – | – | – | – | 37.2% | 36.0% | 37.8% |
| Cash from operations to profit | – | – | – | -57.0% | – | 27.0% | 34.0% |
| Effective tax rate | 1.2% | 14.1% | 1.4% | 19.7% | 28.7% | 23.9% | 20.2% |
Please find attached the monitoring agency report for the quarter ended September 30, 2026
Morepen hits record Q2 revenue of Rs. 755 Cr; EBITDA surges 273% to Rs. 132 Cr; CDMO momentum drives Morepen into a new earnings scale; H1 EBITDA reaches Rs. 220 Cr
The financial results for the period ended September 30, 2026.
Morepen strengthens integrated CDMO capabilities with first U.S. ANDA submission
Please find attached the Voting Results and the Scrutinizer Report of 41st Annual General Meeting
Proceedings of 41st Annual General Meeting held on September 26, 2026
ESG Rating.
Business Update First Phase of Manufacturing Capacity Expansion Completed Ahead of Schedule